Format

Send to

Choose Destination
PLoS One. 2017 Dec 4;12(12):e0188980. doi: 10.1371/journal.pone.0188980. eCollection 2017.

A unique plasma microRNA profile defines type 2 diabetes progression.

Author information

1
Department of Diabetology and Dysmetabolic Diseases, IRCCS MultiMedica, Milan, Italy.
2
Department of Molecular and Translational Medicine, University of Brescia, Brescia Italy.
3
Laboratory of Immunology, Institute of Endocrinology and Experimental Oncology, National Research Council (IEOS-CNR), Naples, Italy.
4
Department of Molecular Medicine and Medical Biotechnology, University of Naples "Federico II", Naples, Italy.
5
Insititut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), C/Rosselló, Barcelona, Spain.
6
Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Barcelona, Spain.

Abstract

A major unmet medical need to better manage Type 2 Diabetes (T2D) is the accurate disease prediction in subjects who show glucose dysmetabolism, but are not yet diagnosed as diabetic. We investigated the possibility to predict/monitor the progression to T2D in these subjects by retrospectively quantifying blood circulating microRNAs in plasma of subjects with i) normal glucose tolerance (NGT, n = 9); ii) impaired glucose tolerance (IGT, n = 9), divided into non-progressors (NP, n = 5) and progressors (P, n = 4) based on subsequent diabetes occurrence, and iii) newly diagnosed T2D (n = 9). We found that impaired glucose tolerance associated with a global increase of plasma circulating microRNAs. While miR-148 and miR-222 were specifically modulated in diabetic subjects and correlated with parameters of glucose tolerance, the most accentuated microRNA dysregulation was found in NP IGT subjects, with increased level of miR-122, miR-99 and decreased level of let-7d, miR-18a, miR-18b, miR-23a, miR-27a, miR-28 and miR-30d in comparison with either NGT or T2D. Interestingly, several of these microRNAs significantly correlated with parameters of cholesterol metabolism. In conclusion, we observed the major perturbation of plasma circulating microRNA in NP pre-diabetic subjects and identified a unique microRNA profile that may become helpful in predicting diabetic development.

PMID:
29200427
PMCID:
PMC5714331
DOI:
10.1371/journal.pone.0188980
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Public Library of Science Icon for PubMed Central
Loading ...
Support Center